IgM antiphospholipid antibodies are associated with a microvascular phenotype in antiphospholipid syndrome

Abstract Background The clinical significance of IgM antiphospholipid antibodies (aPL) in antiphospholipid syndrome (APS) remains uncertain, while lupus anticoagulant is a well-established marker for thrombotic risk. Methods The objective of the study is to evaluate the impact of IgM aPL on the clin...

Descrición completa

Detalles Bibliográficos

Principais autores:	Flavio Signorelli, Fernanda Oliveira de Andrade Lopes, Andreia Coimbra Sousa Gomes, Gustavo Guimarães Moreira Balbi, Irene Cecchi, Massimo Radin, Savino Sciascia, Danieli Castro Oliveira de Andrade
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2026-06-01
Series:	Advances in Rheumatology
Assuntos:	Antiphospholipid syndrome Antiphospholipid antibodies Lupus anticoagulant
Acceso en liña:	https://doi.org/10.1186/s42358-026-00553-z
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!